You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
京東健康2024年業績超市場預期 醫藥零售業務表現強勁
格隆匯 03-06 17:24

3月6日,京東健康(6618.HK)發佈2024年全年業績公告。公告顯示,京東健康2024年總收入爲人民幣582億元,非國際財務報告準則指標下(Non-IFRS)淨利潤達47.9億元,收入和淨利潤均超過市場預期。其中,醫藥零售業務表現持續強勁。

報告期內,藥品等核心優勢品類的市佔份額繼續擴大,用戶黏性也持續增強,展現其醫藥零售業務的領先地位。其中,京東健康與藥企關係繼續強化,實現多款新特藥線上首發;全面發力即時零售業務,在多地開展"網上買藥醫保個賬支付"試點、探索零售藥房新型門店模式,持續強化京東買藥用戶心智。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account